Trinity Biotech (TRIB) Cash from Restructuring (2013)
Trinity Biotech's (TRIB) quarterly Cash from Restructuring came in at $690000.0 in Q4 2013.
Powered by 
Analysis
Trinity Biotech (TRIB) Cash from Restructuring (2013) Analysis & Trends
Trinity Biotech has disclosed Cash from Restructuring across 1 years of filings, most recently posting $690000.0 for Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.82 Bn | 27.71 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.58 Bn | 5.98 Bn | 241.86 Mn |
| 3 | Heartflow | 4.13 Bn | 3.76 Bn | 53.19 Mn |
| 4 | Neogen | 2.57 Bn | 2.39 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.99 Bn | 1.86 Bn | 23.29 Mn |
| 6 | Ceribell | 927.22 Mn | 797.96 Mn | 25.94 Mn |
| 7 | QuidelOrtho | 880.39 Mn | 756.99 Mn | - |
| 8 | Varex Imaging | 778.85 Mn | 679.65 Mn | 76.70 Mn |
| 9 | Prenetics Global | 339.43 Mn | 280.38 Mn | 30.20 Mn |
| 10 | Trinity Biotech | 5.47 Mn | 5.47 Mn | - |